Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
Plans to double its manufacturing footprint to bolster the growth
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
Zeebon is the largest diagnostics services provider in North-Eastern states
Dahiwadkar currently heads four technology companies- WipeOut Inc, Cognota Healthcare Technologies, IT Shastra India and Moringa Techsolv, which he has founded
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Subscribe To Our Newsletter & Stay Updated